Neos Therapeutics Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Neos Therapeutics (NEOS) Tops Q1 EPS by 5c, Revenues Beat
May 9, 2019 7:14 AM EDTNeos Therapeutics (NASDAQ: NEOS) reported Q1 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $14.63 million versus the consensus estimate of $13.88 million.
We continued to make solid progress as we execute our new commercial strategy for our ADHD... More



